NEURO61

Presentation information

Print

[held on paper]Nominees for the Best Presentation Award for the International Participants

[APe-01] Nominees for the Best Presentation Award for the International Participants
Nominees for the Best Presentation Award for the International Participants

[APe-01-4] Results of thirty-six-month amyloid PET: continuous reduction in amyloid burden with gantenerumab

○Gregory Klein1, Paul Delmar2, Geoffrey A. Kerchner2, Carsten Hofmann2, Danielle Abi-saab2, Smiljana Ristic3, Andrew Davis3, Nicola Voyle3, Hironori Tatsuda4, Monika Baudler2, Paulo Fontoura2, Rachelle Doody5 (1.Roche Pharma Research and Early Development, Switzerland, 2.Roche/Genentech Product Development, 3.Roche Products Ltd., 4.Chugai Pharmaceutical Co., Ltd., 5.Genentech, Inc.)

Abstract password authentication.
Password is written on a pocket program and name badge.

Password